BAKER BROS. ADVISORS LP 13D and 13G filings for Monte Rosa Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:18 pm Purchase | 2026-03-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | BAKER BROS. ADVISORS LP | 8,876,346 9.990% | 4,530,610 (+104.25%) | Filing |
| 2026-02-17 4:10 pm Sale | 2025-12-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | BAKER BROS. ADVISORS LP | 4,345,736 6.700% | -570,359 (-11.60%) | Filing |
| 2024-02-14 4:21 pm Purchase | 2023-12-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | BAKER BROS. ADVISORS LP | 4,916,095 9.800% | 4,916,095 (New Position) | Filing |